Currently out of the existing stock ratings of Kevin Heal, 75 are a BUY (79.79%), 18 are a HOLD (19.15%), 1 are a SELL (1.06%).

Kevin Heal

Work Performance Price Targets & Ratings Chart

Analyst Kevin Heal, currently employed at ARGUS, carries an average stock price target met ratio of 80.43% that have a potential upside of 31.6% achieved within 499 days.

Kevin Heal’s has documented 172 price targets and ratings displayed on 23 stocks. The coverage is on Financial Services, Technology sectors.

Most recent stock forecast was given on RJF, Raymond James Financial at 30-Jul-2026.

Wall Street Analyst Kevin Heal

Analyst best performing recommendations are on COIN (COINBASE GLOBAL).
The best stock recommendation documented was for CB (CHUBB LTD) at 5/6/2020. The price target of $115 was fulfilled within 29 days with a profit of $28.63 (33.15%) receiving and performance score of 11.43.

Average potential price target upside

AGNC AGNC Investment Corp AMP Ameriprise Financial CBOE Cboe Global Markets CFG Citizens Financial Group NLY Annaly Capital Management NRZ New Residential Investment Corp ZION Zions Bancorporation CB Chubb Ltd CME CME Group NDAQ Nasdaq RF Regions Financial TRV The Travelers Companies ALL The Allstate HBAN Huntington Bancshares RKT Rocket Companies  CMA Comerica MET MetLife UWMC UWM Holdings Corp ICE Intercontinental Exchange MKTX MarketAxess Holdings COIN Coinbase Global CM Canadian Imperial Bank Of Commerce RJF Raymond James Financial

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 22-Jul-2026

$11

$0.16 (1.48%)

$12

Hold Since 22-Jul-2026

$11

$0.16 (1.48%)

$12

Buy Since 20-Feb-2024

$11.5

$0.66 (6.09%)

$11

Buy Since 24-Oct-2023

$12

$1.16 (10.70%)

$10.5

Show more analysts

Please expand the browser size to see the chart

Which stock is Kevin Heal is most bullish on?

Potential upside of $19.44 has been obtained for RJF (RAYMOND JAMES FINANCIAL)

Which stock is Kevin Heal is most reserved on?

Potential downside of -$0 has been obtained for MKTX (MARKETAXESS HOLDINGS)

What Year was the first public recommendation made by Kevin Heal?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?